G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 57 filers reported holding G1 THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $296,000 | +16.1% | 11,200 | 0.0% | 0.11% | -9.3% |
| Q3 2019 | $255,000 | -94.3% | 11,200 | -92.3% | 0.12% | -92.9% |
| Q2 2019 | $4,472,000 | +174.2% | 146,000 | +48.3% | 1.66% | +175.0% |
| Q1 2019 | $1,631,000 | -43.4% | 98,482 | +36.8% | 0.60% | -56.0% |
| Q3 2018 | $2,884,000 | -7.6% | 72,000 | 0.0% | 1.37% | +14.4% |
| Q2 2018 | $3,121,000 | -18.1% | 72,000 | -30.1% | 1.20% | -19.4% |
| Q1 2018 | $3,813,000 | +393.3% | 103,000 | +164.1% | 1.49% | +444.7% |
| Q4 2017 | $773,000 | -20.4% | 39,000 | 0.0% | 0.27% | -27.8% |
| Q3 2017 | $971,000 | – | 39,000 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 650,000 | $3,529,500 | 0.92% |
| CHI Advisors LLC | 333,945 | $1,813,321 | 0.48% |
| PVG ASSET MANAGEMENT CORP | 15,585 | $84,626 | 0.37% |
| Rhenman & Partners Asset Management AB | 370,000 | $2,009,100 | 0.21% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 184,000 | $999,120 | 0.18% |
| Birchview Capital, LP | 40,000 | $217 | 0.15% |
| XTX Topco Ltd | 102,282 | $555,391 | 0.12% |
| Tekla Capital Management LLC | 423,869 | $2,301,609 | 0.09% |
| Woodline Partners LP | 1,028,967 | $5,587,291 | 0.08% |
| Curi Wealth Management, LLC | 81,009 | $439,879 | 0.06% |